Synergistic Oncolytic Virus System for Enhanced Cancer Treatment
Legal Citation
Summary of the Inventive Concept
A novel oncolytic virus system integrating AI, IoT, blockchain, and advanced materials to enhance cancer treatment outcomes and patient care
Background and Problem Solved
The original patent disclosed an oncolytic virus growth method and antitumor agent, but its effectiveness was limited by the lack of personalized treatment strategies, inefficient data management, and inadequate delivery systems. The new inventive concept addresses these limitations by combining the oncolytic virus with cutting-edge technologies to create a more powerful and targeted cancer treatment system
Detailed Description of the Inventive Concept
The system comprises an oncolytic virus, a blockchain-based data management system for secure and transparent patient information tracking, a machine learning algorithm for predicting optimal treatment regimens, and an IoT-based sensor for real-time monitoring of patient vital signs. Additionally, the system incorporates nanoparticle-based delivery systems and graphene-based materials for targeted and efficient delivery of the oncolytic virus. The AI-based recommendation engine selects optimal treatment strategies based on patient data and treatment outcomes, ensuring personalized care
Novelty and Inventive Step
The new claims introduce a synergistic combination of distinct technologies, including AI, IoT, blockchain, and advanced materials, which are not obvious from the original patent. The integration of these technologies enables a more effective, targeted, and personalized cancer treatment system
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms, varying IoT sensor configurations, or the incorporation of other advanced materials. Additionally, the system could be adapted for use in treating other diseases or conditions
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the cancer treatment market, with potential applications in personalized medicine, precision oncology, and healthcare technology. The market for cancer treatment is projected to grow significantly in the coming years, driven by the increasing incidence of cancer and the need for more effective treatment options
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K35/768 |
| A | A61 | A61K31/282 |
| A | A61 | A61K31/4745 |
| A | A61 | A61K31/513 |
| A | A61 | A61P35/00 |
| C | C12 | C12N7/00 |
| C | C12 | C12N2770/32332 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Oncology, virology, and cancer treatment technologies, specifically involving oncolytic viruses, drug delivery systems, and personalized medical interventions. Requires advanced knowledge of molecular biology, biotechnology, and medical informatics
Person of Ordinary Skill (PHOSITA) Profile
A researcher or medical professional with a PhD in molecular biology or oncology, expertise in viral therapeutics, familiarity with advanced computational methods, and understanding of cancer treatment strategies
Obviousness Rationale
A PHOSITA would recognize that integrating computational technologies with existing oncolytic virus treatment methods represents a natural progression of personalized medicine. The combination of blockchain, AI, and advanced materials with established viral therapy techniques follows predictable technological convergence patterns. The PTD's variations demonstrate incremental improvements that would be evident to a skilled practitioner seeking enhanced treatment precision and monitoring capabilities.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,584 |
|---|---|
| Title | Oncolytic virus growth method and antitumor agent |
| Assignee(s) | KABUSHIKI KAISHA YAKULT HONSHA |